Xometry, Inc. Class A Common Stock
XMTR
$93.14
+6.95%
Xometry, Inc. is a technology-driven marketplace for on-demand manufacturing, connecting buyers with a vast network of suppliers for services like CNC machining, 3D printing, injection molding, and die casting. The company leverages AI-enabled quoting and manufacturing software to streamline the procurement process, positioning itself as a digital disruptor in the traditional manufacturing industry. Currently, the stock is in focus due to its strong revenue growth, driven by expansion in its supplier network and international operations, alongside ongoing efforts to improve profitability and achieve adjusted EBITDA breakeven. Investor sentiment is mixed, balancing optimism about the company's scalable platform and market share gains against concerns about its path to sustained profitability and competitive pressures.…
XMTR
Xometry, Inc. Class A Common Stock
$93.14
Investment Opinion: Should I buy XMTR Today?
Based on the analysis, Xometry is rated a 'Buy' with a thesis that its strong revenue growth and market position in AI-enabled manufacturing justify its premium valuation, despite current unprofitability. The consensus analyst rating is 'Buy' with an average target price of $103.13, implying an upside of 11.7% from the current price of $92.34. Supporting evidence includes the robust revenue growth (annualized revenue of $1.23 billion), a gross margin of 39.1%, and a strong current ratio of 3.76, which provides financial flexibility. However, the negative operating margin and high PS ratio are concerns. The rating would be downgraded to 'Hold' if revenue growth decelerates below 20% or if the PS ratio exceeds 5.5, and upgraded to 'Strong Buy' if the company achieves positive operating income. Overall, the stock is fairly valued relative to its growth prospects, but investors should be aware of the risks.
Sign up to view all
XMTR 12-Month Price Forecast
The AI assessment leans bullish, driven by Xometry's strong revenue growth and market position, but with medium confidence due to valuation and profitability concerns. The company's ability to achieve profitability is the key factor. If Xometry can demonstrate improving margins and reach adjusted EBITDA breakeven within the next 12 months, the stock could re-rate higher. Conversely, if growth slows or losses widen, the stance would be downgraded to neutral or bearish. Monitoring quarterly earnings and margin trends will be crucial.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Xometry, Inc. Class A Common Stock's 12-month outlook, with a consensus price target around $109.13 and implied upside of +17.2% versus the current price.
Average Target
$109.13
0 analysts
Implied Upside
+17.2%
vs. current price
Analyst Count
—
covering this stock
Price Range
$95 - $126
Analyst target range
Xometry is covered by 8 analysts, with a consensus recommendation of 'Buy' (mean rating of 1.78). The average target price is $103.13, implying an upside of approximately 11.7% from the current price of $92.34. The target range spans from $78.00 (low) to $126.00 (high), indicating a wide dispersion in expectations. The high target suggests that some analysts anticipate continued strong growth and margin expansion, while the low target reflects concerns about competitive pressures and potential profitability challenges. The relatively wide spread between the low and high targets highlights the uncertainty surrounding the company's future performance, but the overall bullish consensus suggests that analysts are optimistic about Xometry's long-term prospects.
Bulls vs Bears: XMTR Investment Factors
Xometry presents a compelling growth story with strong revenue momentum and a scalable AI-enabled marketplace, but it carries significant risks due to its premium valuation and current unprofitability. The bull case is supported by the company's exceptional revenue growth, strong liquidity, and analyst consensus, while the bear case highlights the high PS ratio, negative margins, and volatility. Currently, the bull case has stronger evidence given the company's market leadership and improving profitability trajectory, but the key tension is whether Xometry can achieve sustained profitability to justify its valuation. If the company continues to grow revenue at a rapid pace and reaches adjusted EBITDA breakeven, the stock could re-rate higher; however, any slowdown in growth or margin expansion could lead to a sharp de-rating.
Bullish
- Exceptional Revenue Growth: Xometry's latest quarterly revenue is estimated at $1.23 billion (annualized), reflecting a strong growth trajectory. The company's 1-year price change of +108.5% significantly outperforms the S&P 500's +22.6%, indicating robust market confidence in its expansion.
- Strong Liquidity Position: With a current ratio of 3.76, Xometry has ample short-term liquidity to fund operations and growth initiatives. This financial cushion reduces near-term solvency risk and supports continued investment in its marketplace platform.
- Analyst Consensus Buy: The consensus recommendation is 'Buy' with a mean rating of 1.78, and the average analyst target price of $103.13 implies an upside of approximately 11.7% from the current price of $92.34. This indicates that analysts see further appreciation potential.
- Market Leadership in AI-Enabled Manufacturing: Xometry is a pioneer in AI-enabled manufacturing, leveraging technology to disrupt traditional procurement. Its scalable platform and growing supplier network provide a competitive moat, as evidenced by its ability to achieve a 108.5% stock price increase over the past year.
Bearish
- Premium Valuation with Negative Earnings: Xometry trades at a PS ratio of 4.40 and EV/Sales of 6.34, which is elevated for a company with negative net income (net margin -9.0%). The trailing PE is -48.7, reflecting current unprofitability, and the PEG ratio is -2.64, indicating that growth is not yet translating into earnings.
- High Volatility and Drawdown Risk: The stock has a beta of 1.316, indicating higher volatility than the market. Its max drawdown of -49.93% demonstrates significant downside risk, and the recent pullback from the 52-week high of $106.08 to $92.34 (a -13% decline) highlights potential overextension.
- Negative Returns on Equity and Assets: ROE is -22.4% and ROA is -3.1%, indicating that the company is not generating returns for shareholders. This is common for high-growth companies, but it underscores the risk that profitability may take longer than expected.
- Moderate Debt Levels: The debt-to-equity ratio of 1.27 suggests moderate leverage, which could strain cash flows if growth slows. While the current ratio is strong, the reliance on debt to fund operations adds financial risk.
XMTR Technical Analysis
Xometry's stock has exhibited a robust long-term uptrend, with a 1-year price change of +108.5%, significantly outperforming the S&P 500's +22.6% over the same period. The current price of $92.34 sits at 87% of its 52-week range (low: $35.86, high: $106.08), indicating the stock is trading near its highs, reflecting strong momentum but also potential overextension. The 6-month price change of +39.8% further underscores the sustained bullish trend, though the stock has pulled back from its July peak of $106.08, suggesting some consolidation.
Beta
1.32
1.32x market volatility
Max Drawdown
-49.9%
Largest decline past year
52-Week Range
$36-$106
Price range past year
Annual Return
+116.2%
Cumulative gain past year
| Period | XMTR Return | S&P 500 |
|---|---|---|
| 1m | +4.1% | +2.4% |
| 3m | +16.4% | +4.6% |
| 6m | +41.1% | +11.7% |
| 1y | +116.2% | +21.4% |
| ytd | +48.4% | +13.4% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
XMTR Fundamental Analysis
Xometry's revenue growth remains robust, with the latest quarterly revenue estimated at $1.23 billion (annualized), reflecting a strong trajectory. The company's gross margin stands at 39.1%, which is typical for a marketplace business, but its operating margin is negative at -6.6%, indicating ongoing investments in growth. Net income is negative, with an EPS of -$0.02, but the loss is narrowing as the company scales. The current ratio of 3.76 indicates strong liquidity, while a debt-to-equity ratio of 1.27 suggests moderate leverage. Free cash flow is not explicitly provided, but the negative ROE of -22.4% highlights that the company is not yet generating returns for shareholders, though this is common for high-growth companies in their expansion phase.
Quarterly Revenue
N/A
N/A
Revenue YoY Growth
N/A
YoY Comparison
Gross Margin
N/A
Latest Quarter
Free Cash Flow
N/A
Last 12 Months
Open an Account, get $2 TSLA now!
Valuation Analysis: Is XMTR Overvalued?
Given that Xometry has negative net income, the price-to-sales (PS) ratio is the most appropriate valuation metric. The current PS ratio is 4.40, which is elevated compared to the broader industrials sector, reflecting the market's high growth expectations. The forward PE of 70.3 suggests that analysts expect significant earnings growth in the coming year, but the negative trailing PE (-48.7) indicates current unprofitability. Compared to the industry average PS ratio (not provided), Xometry trades at a premium, which is justified by its superior revenue growth and market position. Historically, the stock has traded at a wide PS range, and the current level is near the higher end, implying that the market is pricing in optimistic future growth. The EV/Sales ratio of 6.34 further confirms the premium valuation.
PE
-48.7x
Latest Quarter
vs. Historical
N/A
5-Year PE Range 17x~59x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
-89.5x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: Xometry's financials reveal a company in growth mode, but with notable risks. The negative operating margin of -6.6% and net margin of -9.0% indicate that the company is spending heavily to scale, which could pressure cash flows if growth decelerates. The debt-to-equity ratio of 1.27 suggests moderate leverage, and while the current ratio of 3.76 provides liquidity, the reliance on debt to fund operations adds financial risk. Additionally, the negative ROE of -22.4% shows that the company is not yet generating returns for shareholders, and the high PS ratio of 4.40 implies that the market is pricing in significant future growth, leaving little room for error.
FAQ
The key risks of holding Xometry include: 1) Financial risk: negative operating margin (-6.6%) and net margin (-9.0%) indicate ongoing losses, and the debt-to-equity ratio of 1.27 adds leverage risk. 2) Competitive risk: the on-demand manufacturing market is competitive, and Xometry could lose market share to rivals like Protolabs. 3) Macro risk: with a beta of 1.316, the stock is sensitive to market downturns, and a recession could reduce manufacturing demand. 4) Company-specific risk: the high PS ratio of 4.40 leaves little room for error, and any growth deceleration could lead to a sharp sell-off. The most severe risk is a combination of these factors, potentially driving the stock down to the 52-week low of $35.86, a -61% decline from the current price.
The 12-month forecast for Xometry is based on three scenarios: a bull case with a 30% probability and a target range of $110-$126, driven by faster-than-expected growth and profitability; a base case with a 50% probability and a target range of $95-$110, aligning with the analyst average target of $103.13; and a bear case with a 20% probability and a target range of $70-$85, reflecting slower growth or competitive pressures. The most likely scenario is the base case, assuming the company maintains its growth trajectory and gradually improves margins. Investors should monitor quarterly earnings for signs of margin expansion or deterioration.
Xometry is trading at a premium valuation, with a PS ratio of 4.40 and EV/Sales of 6.34, which is high for a company with negative net income. Compared to the broader industrials sector, this premium is justified by its superior revenue growth and market position. The forward PE of 70.3 indicates that analysts expect significant earnings growth, but the negative trailing PE (-48.7) shows current unprofitability. The market is pricing in optimistic future growth, and any disappointment could lead to multiple compression. Therefore, the stock is fairly valued relative to its growth prospects, but it is not cheap.
Xometry is a good buy for investors with a high risk tolerance and a long-term horizon, given its strong revenue growth and market position. The analyst consensus is 'Buy' with an average target price of $103.13, implying an upside of 11.7% from the current price of $92.34. However, the stock is not suitable for conservative investors due to its negative earnings and high volatility (beta 1.316). The biggest downside risk is a potential de-rating if growth slows, which could lead to a decline towards the 52-week low of $35.86. Overall, it is a buy for growth-oriented investors who believe in the company's ability to achieve profitability.
Xometry is more suitable for long-term investment due to its high growth potential and current unprofitability. The stock has a beta of 1.316, indicating high volatility, which makes it risky for short-term trading. The company is in its growth phase, and it may take several years to achieve sustained profitability. Therefore, a minimum holding period of 3-5 years is recommended to allow the company to scale and realize its market opportunity. Short-term investors may benefit from momentum, but they face significant risk of drawdowns, as evidenced by the -49.93% max drawdown. Long-term investors should focus on the company's revenue growth and path to profitability.